What is Biohaven's compensation and benefits?

Biohaven (BHVN) reported compensation and benefits of $4.43M in Q1 2026.

How has Biohaven's compensation and benefits changed year-over-year?

Biohaven's compensation and benefits decreased by 32.1% year-over-year, from $6.53M to $4.43M.

What is the long-term trend for Biohaven's compensation and benefits?

Over 4 years (2021 to 2025), Biohaven's compensation and benefits has grown at a 15.2% compound annual growth rate (CAGR), from $9.54M to $16.78M.

Biohaven BHVN Compensation and benefits

Compensation and benefits at other companies

Eli LillyLLY

——

Roivant SciencesROIV

——

Nurix Therapeutics, Inc.NRIX

——

Viridian Therapeutics, Inc.VRDN

——

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.25B-48.1%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's compensation and benefits?: Biohaven (BHVN) reported compensation and benefits of $4.43M in Q1 2026.
How has Biohaven's compensation and benefits changed year-over-year?: Biohaven's compensation and benefits decreased by 32.1% year-over-year, from $6.53M to $4.43M.
What is the long-term trend for Biohaven's compensation and benefits?: Over 4 years (2021 to 2025), Biohaven's compensation and benefits has grown at a 15.2% compound annual growth rate (CAGR), from $9.54M to $16.78M.